• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级参考医院在罕见神经疾病研究中的经验。

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases.

机构信息

2nd Department of Neurology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Laboratory of Experimental Neurology and Neuroimmunology, 2nd Department of Neurology, AHEPA University Hospital, 54636 Thessaloniki, Greece.

出版信息

Medicina (Kaunas). 2023 Jan 30;59(2):266. doi: 10.3390/medicina59020266.

DOI:10.3390/medicina59020266
PMID:36837468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9959728/
Abstract

Rare diseases (RDs) are life-threatening or chronically impairing conditions that affect about 6% of the world's population. RDs are often called 'orphan' diseases, since people suffering from them attract little support from national health systems. The aim of this study is to describe the clinical characteristics of, and the available laboratory examinations for, patients who were hospitalized in a tertiary referral center and finally received a diagnosis associated with a Rare Neurological Disease (RND). Patients that were hospitalized in our clinic from 1 January 2014 to 31 March 2022 and were finally diagnosed with an RND were consecutively included. The RND classification was performed according to the ORPHAcode system. A total of 342 out of 11.850 (2.9%) adult patients admitted to our department during this period received a diagnosis associated with an RND. The most common diagnosis (N = 80, 23%) involved an RND presenting with dementia, followed by a motor neuron disease spectrum disorder (N = 64, 18.7%). Family history indicative of an RND was present in only 21 patients (6.1%). Fifty-five (16%) people had previously been misdiagnosed with another neurological condition. The mean time delay between disease onset and diagnosis was 4.24 ± 0.41 years. Our data indicate that a broad spectrum of RNDs may reach a tertiary Neurological Center after a significant delay. Moreover, our data underline the need for a network of reference centers, both at a national and international level, expected to support research on the diagnosis and treatment of RND.

摘要

罕见病(RDs)是危及生命或慢性致残的疾病,影响全球约 6%的人口。RDs 通常被称为“孤儿病”,因为患有这些疾病的人很少得到国家卫生系统的支持。本研究旨在描述在三级转诊中心住院并最终诊断为罕见神经疾病(RND)的患者的临床特征和可用的实验室检查。从 2014 年 1 月 1 日至 2022 年 3 月 31 日,连续纳入在我们诊所住院且最终诊断为 RND 的患者。RND 分类按照 ORPHAcode 系统进行。在此期间,我院共收治 11850 名成年患者中的 342 名(2.9%)被诊断为与 RND 相关的疾病。最常见的诊断(N=80,23%)为以痴呆为表现的 RND,其次是运动神经元疾病谱障碍(N=64,18.7%)。仅有 21 名患者(6.1%)存在提示 RND 的家族史。55 名患者(16%)曾被误诊为另一种神经疾病。从发病到确诊的平均时间延迟为 4.24±0.41 年。我们的数据表明,广泛的 RND 可能会在显著延迟后到达三级神经科中心。此外,我们的数据强调了需要建立一个包括国家和国际层面的参考中心网络,以支持 RND 的诊断和治疗研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/a94a4235e0ab/medicina-59-00266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/e4f3fcb4af0d/medicina-59-00266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/ddff4c437a96/medicina-59-00266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/6d67309fd733/medicina-59-00266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/a94a4235e0ab/medicina-59-00266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/e4f3fcb4af0d/medicina-59-00266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/ddff4c437a96/medicina-59-00266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/6d67309fd733/medicina-59-00266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/9959728/a94a4235e0ab/medicina-59-00266-g004.jpg

相似文献

1
The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases.三级参考医院在罕见神经疾病研究中的经验。
Medicina (Kaunas). 2023 Jan 30;59(2):266. doi: 10.3390/medicina59020266.
2
Prevalence and healthcare utilization of rare neurological diseases in Hong Kong: 2014-2018.香港罕见神经系统疾病的患病率和医疗保健利用情况:2014-2018 年。
Eur J Neurol. 2021 Jul;28(7):2305-2312. doi: 10.1111/ene.14852. Epub 2021 Apr 20.
3
Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).儿童到成人的过渡:欧洲罕见神经疾病参考网络(ERN-RND)内当前实践的调查。
Neurol Sci. 2024 Mar;45(3):1007-1016. doi: 10.1007/s10072-023-07101-3. Epub 2023 Oct 19.
4
The European Reference Network for Rare Neurological Diseases.欧洲罕见神经系统疾病参考网络。
Front Neurol. 2021 Jan 14;11:616569. doi: 10.3389/fneur.2020.616569. eCollection 2020.
5
Establishing and boosting communication in the European Reference Network for Rare Neurological Diseases (ERN-RND): the impact of offering free educational webinars.建立和加强欧洲罕见神经疾病参考网络(ERN-RND)的沟通:提供免费教育网络研讨会的影响。
Orphanet J Rare Dis. 2022 Mar 2;17(1):89. doi: 10.1186/s13023-022-02209-9.
6
Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseases.罕见神经系统疾病患者最佳跨学科管理和医疗保健环境的建议。
Orphanet J Rare Dis. 2024 Feb 13;19(1):62. doi: 10.1186/s13023-024-03023-1.
7
Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).罕见神经系统疾病:神经科的潘多拉之盒(欧洲和意大利视角)。
Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S12-7. doi: 10.1016/S0035-3787(13)70054-7.
8
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
9
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.罕见病诊断延迟:来自西班牙罕见病患者登记处的数据。
Orphanet J Rare Dis. 2022 Nov 17;17(1):418. doi: 10.1186/s13023-022-02530-3.
10
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases.欧洲神经病学学会关于制定和报告罕见神经系统疾病临床实践指南的指南。
Eur J Neurol. 2022 Jun;29(6):1571-1586. doi: 10.1111/ene.15267. Epub 2022 Mar 23.

引用本文的文献

1
The impact of COVID-19 pandemic on dermatology patients with rare skin diseases.2019年冠状病毒病大流行对患有罕见皮肤病患者的影响。
Dermatol Reports. 2024 Feb 2;16(4):9879. doi: 10.4081/dr.2024.9879. eCollection 2024 Nov 21.
2
Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.罕见神经疾病中的饮食与营养:生物学、生物化学和病理生理学证据。
Nutrients. 2024 Sep 15;16(18):3114. doi: 10.3390/nu16183114.
3
Machine learning characterization of a rare neurologic disease via electronic health records: a proof-of-principle study on stiff person syndrome.

本文引用的文献

1
Criteria to define rare diseases and orphan drugs: a systematic review protocol.定义罕见病和孤儿药的标准:系统评价方案。
BMJ Open. 2022 Jul 29;12(7):e062126. doi: 10.1136/bmjopen-2022-062126.
2
Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral center.2019年冠状病毒病大流行对罕见病患者住院情况的影响:意大利南部一家转诊中心的经验
Int J Dermatol. 2022 Jul;61(7):e237-e238. doi: 10.1111/ijd.16236. Epub 2022 May 10.
3
A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.
基于电子健康记录的罕见神经系统疾病的机器学习特征分析:僵人综合征的原理验证研究。
BMC Neurol. 2024 Aug 3;24(1):272. doi: 10.1186/s12883-024-03760-7.
希腊神经免疫学学会(HEL.A.NI.)关于新冠病毒肺炎和多发性硬化症的全国代表性横断面研究:总体影响及接种意愿
Front Neurol. 2021 Nov 25;12:757038. doi: 10.3389/fneur.2021.757038. eCollection 2021.
4
Progressive multifocal leukoencephalopathy in an elderly immunocompetent-appearing patient: Relevance with L-selectin (CD62L) expression and immunosenescence.免疫功能正常的老年患者进行性多灶性白质脑病:与 L-选择素(CD62L)表达和免疫衰老的相关性。
Clin Neurol Neurosurg. 2021 Jun;205:106625. doi: 10.1016/j.clineuro.2021.106625. Epub 2021 Apr 1.
5
Diagnosis of Rare Diseases: a scoping review of clinical decision support systems.罕见病诊断:临床决策支持系统的范围综述。
Orphanet J Rare Dis. 2020 Sep 24;15(1):263. doi: 10.1186/s13023-020-01536-z.
6
Impact of COVID-19 pandemic on patients with rare disease in Hong Kong.新冠疫情对香港罕见病患者的影响。
Eur J Med Genet. 2020 Dec;63(12):104062. doi: 10.1016/j.ejmg.2020.104062. Epub 2020 Sep 12.
7
Rare Genetic Diseases: Nature's Experiments on Human Development.罕见遗传病:人类发育的自然实验
iScience. 2020 May 22;23(5):101123. doi: 10.1016/j.isci.2020.101123. Epub 2020 May 1.
8
Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases.欧洲罕见运动障碍的管理:欧洲罕见神经疾病参考网络调查结果
Eur J Neurol. 2020 Aug;27(8):1493-1500. doi: 10.1111/ene.14302. Epub 2020 Jun 19.
9
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.在用那他珠单抗治疗的复发缓解型多发性硬化症(RRMS)患者中,T细胞中L-选择素表达降低与淋巴细胞相对增加相关——对进行性多灶性白质脑病(PML)风险的功能影响。
Neurol Res. 2020 Mar;42(3):209-221. doi: 10.1080/01616412.2020.1722913. Epub 2020 Feb 12.
10
Uncovering Missing Heritability in Rare Diseases.揭示罕见疾病中的遗传缺失。
Genes (Basel). 2019 Apr 4;10(4):275. doi: 10.3390/genes10040275.